Compare IDR & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDR | FLGT |
|---|---|---|
| Founded | 1996 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical Specialities |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 502.0M | 537.6M |
| IPO Year | 2000 | 2016 |
| Metric | IDR | FLGT |
|---|---|---|
| Price | $35.48 | $18.08 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $28.33 |
| AVG Volume (30 Days) | 210.3K | ★ 388.0K |
| Earning Date | 05-13-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 70.15 | N/A |
| EPS | ★ 0.40 | N/A |
| Revenue | ★ $42,406,253.00 | $18,730,000.00 |
| Revenue This Year | $25.52 | $10.09 |
| Revenue Next Year | N/A | $12.18 |
| P/E Ratio | $90.43 | ★ N/A |
| Revenue Growth | ★ 64.59 | N/A |
| 52 Week Low | $12.40 | $13.46 |
| 52 Week High | $54.70 | $31.04 |
| Indicator | IDR | FLGT |
|---|---|---|
| Relative Strength Index (RSI) | 44.81 | 53.00 |
| Support Level | $33.59 | $13.91 |
| Resistance Level | $41.05 | $19.93 |
| Average True Range (ATR) | 2.85 | 0.79 |
| MACD | 0.29 | -0.16 |
| Stochastic Oscillator | 33.73 | 18.61 |
Idaho Strategic Resources Inc is a vertically integrated, operating junior mining company. The Company's primary business is exploring for, developing, and extracting gold, and to a lesser extent, silver, and base metal mineral resources in the greater Coeur d'Alene Mining District of North Idaho. The Company produces gold at the Golden Chest Mine located in the Murray Gold Belt area of the world-class Coeur d'Alene Mining District, north of the prolific Silver Valley.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.